These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20437119)

  • 1. Cancer therapies and bone health.
    Hu MI; Lu H; Gagel RF
    Curr Rheumatol Rep; 2010 Jun; 12(3):177-85. PubMed ID: 20437119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated bone disease.
    Brown SA; Guise TA
    Curr Osteoporos Rep; 2007 Sep; 5(3):120-7. PubMed ID: 17925193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
    Candelaria-Quintana D; Dayao ZR; Royce ME
    Breast Cancer Res Treat; 2012 Apr; 132(2):355-63. PubMed ID: 21987034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Health in Men with Prostate Cancer: Review Article.
    A M El Badri S; Salawu A; Brown JE
    Curr Osteoporos Rep; 2019 Dec; 17(6):527-537. PubMed ID: 31760582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to prevent chemotherapy-induced bone loss in women with breast cancer.
    Theriault RL
    Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S63-70. PubMed ID: 15807926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiresorptive therapy in the management of cancer treatment-induced bone loss.
    Garg A; Leitzel K; Ali S; Lipton A
    Curr Osteoporos Rep; 2015 Apr; 13(2):73-7. PubMed ID: 25575469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone health in men with prostate cancer: diagnostic and therapeutic considerations.
    Saad F; Perrotte P; Bénard F; McCormack M; Karakiewicz PI
    Can J Urol; 2005 Jun; 12 Suppl 2():9-15. PubMed ID: 16018826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis and bone loss: advancing treatment and prevention.
    Coleman RE; Lipton A; Roodman GD; Guise TA; Boyce BF; Brufsky AM; Clézardin P; Croucher PI; Gralow JR; Hadji P; Holen I; Mundy GR; Smith MR; Suva LJ
    Cancer Treat Rev; 2010 Dec; 36(8):615-20. PubMed ID: 20478658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The skeletal impact of cancer therapies.
    Bedatsova L; Drake MT
    Br J Clin Pharmacol; 2019 Jun; 85(6):1161-1168. PubMed ID: 30723928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing bone health with zoledronic acid: a review of randomized clinical study results.
    Hadji P
    Climacteric; 2011 Jun; 14(3):321-32. PubMed ID: 21182431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal effects of drugs to treat cancer.
    Vestergaard P
    Curr Drug Saf; 2008 Sep; 3(3):173-7. PubMed ID: 18690997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostate cancer and Cancer Treatment-Induced Bone Loss(CTIBL)].
    Matsushima H
    Clin Calcium; 2016 Jul; 26(7):1039-45. PubMed ID: 27346316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing cancer-related skeletal events with bisphosphonates.
    Rule S
    Hosp Med; 2004 Jun; 65(6):355-60. PubMed ID: 15222212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy- and irradiation-induced bone loss in adults with solid tumors.
    Wissing MD
    Curr Osteoporos Rep; 2015 Jun; 13(3):140-5. PubMed ID: 25712619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging and osteoporosis in breast and prostate cancer.
    VanderWalde A; Hurria A
    CA Cancer J Clin; 2011; 61(3):139-56. PubMed ID: 21543824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCCN Task Force Report: Bone Health and Cancer Care.
    Theriault RL; Biermann JS; Brown E; Brufsky A; Demers L; Grewal RK; Guise T; Jackson R; McEnery K; Podoloff D; Ravdin P; Shapiro CL; Smith M; Van Poznak CH
    J Natl Compr Canc Netw; 2006 May; 4 Suppl 2():S1-20; quiz S21-2. PubMed ID: 16737674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary osteoporosis UPDATE. Pathophysiology and management of cancer treatment-induced bone loss/fractures].
    Yoneda T
    Clin Calcium; 2010 May; 20(5):690-9. PubMed ID: 20445280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using biochemical markers of bone turnover in clinical practice.
    Singer FR; Eyre DR
    Cleve Clin J Med; 2008 Oct; 75(10):739-50. PubMed ID: 18939390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic agents for the treatment of bone diseases.
    Lipton A
    Expert Opin Biol Ther; 2005 Jun; 5(6):817-32. PubMed ID: 15952912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.